Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities

  • Chang, Eun Mi (Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam Medical Center, CHA University) ;
  • Song, Hang Seok (Department of Biomedical Science, College of Life Science, CHA University) ;
  • Lee, Dong Ryul (Department of Biomedical Science, College of Life Science, CHA University) ;
  • Lee, Woo Sik (Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam Medical Center, CHA University) ;
  • Yoon, Tae Ki (Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam Medical Center, CHA University)
  • Received : 2013.12.18
  • Accepted : 2014.03.24
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

IVM refers to the maturation of immature oocytes in culture after their recovery from small antral follicles at the stage prior to selection and dominance. IVM requires little or no FSH in vivo and has been proposed as an alternative to conventional IVF, since it reduces the primary adverse effects caused by controlled ovarian stimulation, including the ovarian hyperstimulation syndrome. Moreover, IVM is a promising option for cases for which no standard protocol is suitable, such as FSH resistance, contraindications for ovarian stimulatory drugs, and the need for urgent fertility preservation. Recently, IVM has been used in women with regular cycles and normal ovaries. However, the pregnancy rate following IVM is suboptimal compared with that of conventional IVF, indicating that further studies to optimize the protocol and the culture conditions are warranted.

Keywords

References

  1. Pincus G, Enzmann EV. The comparative behavior of mammalian eggs in vivo and in vitro: I. the activation of ovarian eggs. J Exp Med 1935;62:665-75. https://doi.org/10.1084/jem.62.5.665
  2. Cha KY, Koo JJ, Ko JJ, Choi DH, Han SY, Yoon TK. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 1991;55:109-13.
  3. Cha KY, Chian RC. Maturation in vitro of immature human oocytes for clinical use. Hum Reprod Update 1998;4:103-20. https://doi.org/10.1093/humupd/4.2.103
  4. Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 1994;62:353-62.
  5. Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online 2010;20:634-8. https://doi.org/10.1016/j.rbmo.2010.01.012
  6. Fadini R, Dal Canto M, Mignini Renzini M, Milani R, Fruscio R, Cantu MG, et al. Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer. J Assist Reprod Genet 2012;29:779-81. https://doi.org/10.1007/s10815-012-9768-0
  7. Practice Committees of the American Society for Reproductive Medicine the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril 2013;99:663-6. https://doi.org/10.1016/j.fertnstert.2012.12.031
  8. Yang B, Shi W, Yang J, Liu H, Zhao H, Li X, et al. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy- induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials. Breast 2013;22:150-7. https://doi.org/10.1016/j.breast.2012.12.008
  9. Turan V, Bedoschi G, Moy F, Oktay K. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril 2013;100:1681-5.e1. https://doi.org/10.1016/j.fertnstert.2013.08.030
  10. Donnez J, Silber S, Andersen CY, Demeestere I, Piver P, Meirow D, et al. Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births. Ann Med 2011;43:437-50. https://doi.org/10.3109/07853890.2010.546807
  11. Anderson RA, Wallace WH. Fertility preservation in girls and young women. Clin Endocrinol (Oxf) 2011;75:409-19. https://doi.org/10.1111/j.1365-2265.2011.04100.x
  12. Chian RC, Uzelac PS, Nargund G. In vitro maturation of human immature oocytes for fertility preservation. Fertil Steril 2013;99:1173-81. https://doi.org/10.1016/j.fertnstert.2013.01.141
  13. Prasath EB, Chan ML, Wong WH, Lim CJ, Tharmalingam MD, Hendricks M, et al. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum Reprod 2014;29:276-8. https://doi.org/10.1093/humrep/det420
  14. Cao YX, Chian RC. Fertility preservation with immature and in vitro matured oocytes. Semin Reprod Med 2009;27:456-64. https://doi.org/10.1055/s-0029-1241055
  15. Borini A, Bianchi V. Cryopreservation of mature and immature oocytes. Clin Obstet Gynecol 2010;53:763-74. https://doi.org/10.1097/GRF.0b013e3181f96f01
  16. Fadini R, Dal Canto MB, Renzini MM, Brambillasca F, Comi R, Fumagalli D, et al. Predictive factors in in-vitro maturation in unstimulated women with normal ovaries. Reprod Biomed Online 2009;18:251-61. https://doi.org/10.1016/S1472-6483(10)60263-5
  17. Suikkari AM, Tulppala M, Tuuri T, Hovatta O, Barnes F. Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes. Hum Reprod 2000;15:747-51. https://doi.org/10.1093/humrep/15.4.747
  18. Mikkelsen AL, Lindenberg S. Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. Reproduction 2001;122:587-92. https://doi.org/10.1530/rep.0.1220587
  19. Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online 2009;19:343-51. https://doi.org/10.1016/S1472-6483(10)60168-X
  20. Chian RC, Gulekli B, Buckett WM, Tan SL. Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med 1999;341:1624, 6.
  21. Buckett WM, Chian RC, Tan SL. Human chorionic gonadotropin for in vitro oocyte maturation: does it improve the endometrium or implantation? J Reprod Med 2004;49:93-8.
  22. Siristatidis CS, Vrachnis N, Creatsa M, Maheshwari A, Bhattacharya S. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction. Cochrane Database Syst Rev 2013;10:CD006606.
  23. Kim MK, Park EA, Kim HJ, Choi WY, Cho JH, Lee WS, et al. Does supplementation of in-vitro culture medium with melatonin improve IVF outcome in PCOS? Reprod Biomed Online 2013;26:22-9. https://doi.org/10.1016/j.rbmo.2012.10.007
  24. Maman E, Meirow D, Brengauz M, Raanani H, Dor J, Hourvitz A. Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation. Fertil Steril 2011;95:64-7. https://doi.org/10.1016/j.fertnstert.2010.06.064
  25. Vitek WS, Witmyer J, Carson SA, Robins JC. Estrogen-suppressed in vitro maturation: a novel approach to in vitro maturation. Fertil Steril 2013;99:1886-90. https://doi.org/10.1016/j.fertnstert.2013.01.148
  26. Ortega-Hrepich C, Stoop D, Guzman L, Van Landuyt L, Tournaye H, Smitz J, et al. A "freeze-all" embryo strategy after in vitro maturation: a novel approach in women with polycystic ovary syndrome? Fertil Steril 2013;100:1002-7. https://doi.org/10.1016/j.fertnstert.2013.06.018
  27. Chang EM, Han JE, Seok HH, Lee DR, Yoon TK, Lee WS. Insulin resistance does not affect early embryo development but lowers implantation rate in in vitro maturation-in vitro fertilization-embryo transfer cycle. Clin Endocrinol (Oxf) 2013;79:93-9. https://doi.org/10.1111/cen.12099
  28. Child TJ, Abdul-Jalil AK, Gulekli B, Tan SL. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril 2001;76:936-42. https://doi.org/10.1016/S0015-0282(01)02853-9
  29. Beckers NG, Pieters MH, Ramos L, Zeilmaker GH, Fauser BC, Braat DD. Retrieval, maturation, and fertilization of immature oocytes obtained from unstimulated patients with polycystic ovary syndrome. J Assist Reprod Genet 1999;16:81-6. https://doi.org/10.1023/A:1022516806423
  30. Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 2000;15:165-70. https://doi.org/10.1093/humrep/15.1.165
  31. Soderstrom-Anttila V, Makinen S, Tuuri T, Suikkari AM. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod 2005;20:1534-40. https://doi.org/10.1093/humrep/deh768
  32. Le Du A, Kadoch IJ, Bourcigaux N, Doumerc S, Bourrier MC, Chevalier N, et al. In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience. Hum Reprod 2005;20:420-4. https://doi.org/10.1093/humrep/deh603
  33. Buckett WM, Chian RC, Dean NL, Sylvestre C, Holzer HE, Tan SL. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection. Fertil Steril 2008;90:546-50. https://doi.org/10.1016/j.fertnstert.2007.06.107
  34. De Vos M, Ortega-Hrepich C, Albuz FK, Guzman L, Polyzos NP, Smitz J, et al. Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. Fertil Steril 2011;96:860-4. https://doi.org/10.1016/j.fertnstert.2011.07.1108
  35. Cha KY, Chung HM, Lee DR, Kwon H, Chung MK, Park LS, et al. Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer. Fertil Steril 2005;83:1461-5. https://doi.org/10.1016/j.fertnstert.2004.11.044
  36. Buckett WM, Chian RC, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 2007;110:885-91. https://doi.org/10.1097/01.AOG.0000284627.38540.80
  37. Shu-Chi M, Jiann-Loung H, Yu-Hung L, Tseng-Chen S, Ming IL, Tsu-Fuh Y. Growth and development of children conceived by in-vitro maturation of human oocytes. Early Hum Dev 2006;82:677-82. https://doi.org/10.1016/j.earlhumdev.2006.01.012
  38. Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod 2012;27:3601-8. https://doi.org/10.1093/humrep/des359
  39. Mikkelsen AL. Strategies in human in-vitro maturation and their clinical outcome. Reprod Biomed Online 2005;10:593-9. https://doi.org/10.1016/S1472-6483(10)61666-5
  40. Soderstrom-Anttila V, Salokorpi T, Pihlaja M, Serenius-Sirve S, Suikkari AM. Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes. Hum Reprod 2006;21:1508-13. https://doi.org/10.1093/humrep/dei503
  41. Anckaert E, De Rycke M, Smitz J. Culture of oocytes and risk of imprinting defects. Hum Reprod Update 2013;19:52-66. https://doi.org/10.1093/humupd/dms042
  42. Khoueiry R, Ibala-Rhomdane S, Mery L, Blachere T, Guerin JF, Lornage J, et al. Dynamic CpG methylation of the KCNQ1OT1 gene during maturation of human oocytes. J Med Genet 2008;45:583-8. https://doi.org/10.1136/jmg.2008.057943
  43. Market-Velker BA, Zhang L, Magri LS, Bonvissuto AC, Mann MR. Dual effects of superovulation: loss of maternal and paternal imprinted methylation in a dose-dependent manner. Hum Mol Genet 2010;19:36-51. https://doi.org/10.1093/hmg/ddp465
  44. Li R, Albertini DF. The road to maturation: somatic cell interaction and self-organization of the mammalian oocyte. Nat Rev Mol Cell Biol 2013;14:141-52. https://doi.org/10.1038/nrm3531
  45. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 2004;303:682-4. https://doi.org/10.1126/science.1092463
  46. Ben-Ami I, Komsky A, Bern O, Kasterstein E, Komarovsky D, Ron- El R. In vitro maturation of human germinal vesicle-stage oocytes: role of epidermal growth factor-like growth factors in the culture medium. Hum Reprod 2011;26:76-81. https://doi.org/10.1093/humrep/deq290
  47. Zhao P, Qiao J, Huang S, Zhang Y, Liu S, Yan LY, et al. Gonadotrophin- induced paracrine regulation of human oocyte maturation by BDNF and GDNF secreted by granulosa cells. Hum Reprod 2011;26:695-702. https://doi.org/10.1093/humrep/deq390
  48. Chen J, Hudson E, Chi MM, Chang AS, Moley KH, Hardie DG, et al. AMPK regulation of mouse oocyte meiotic resumption in vitro. Dev Biol 2006;291:227-38. https://doi.org/10.1016/j.ydbio.2005.11.039
  49. Anderiesz C, Fong CY, Bongso A, Trounson AO. Regulation of human and mouse oocyte maturation in vitro with 6-dimethylaminopurine. Hum Reprod 2000;15:379-88. https://doi.org/10.1093/humrep/15.2.379

Cited by

  1. Challenges and Considerations in Optimizing Ovarian Stimulation Protocols in Oncofertility Patients vol.2, pp.None, 2014, https://doi.org/10.3389/fpubh.2014.00246
  2. Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases vol.13, pp.None, 2014, https://doi.org/10.1186/s12958-015-0001-8
  3. The potential role of granulosa cells in the maturation rate of immature human oocytes and embryo development: A co-culture study vol.42, pp.3, 2014, https://doi.org/10.5653/cerm.2015.42.3.111
  4. Assessment of the effect of different vitrification solutions on human ovarian tissue after short‐term xenotransplantation onto the chick embryo chorioallantoic membrane vol.83, pp.4, 2014, https://doi.org/10.1002/mrd.22631
  5. A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing vol.31, pp.4, 2016, https://doi.org/10.1093/humrep/dew025
  6. Novel reproductive technologies to prevent mitochondrial disease vol.23, pp.5, 2014, https://doi.org/10.1093/humupd/dmx018
  7. Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate vol.24, pp.8, 2014, https://doi.org/10.1177/1933719116682873
  8. The Potential of Nanotechnology in Medically Assisted Reproduction vol.8, pp.None, 2014, https://doi.org/10.3389/fphar.2017.00994
  9. Estrogen receptors in granulosa cells govern meiotic resumption of pre-ovulatory oocytes in mammals vol.8, pp.3, 2014, https://doi.org/10.1038/cddis.2017.82
  10. Ovarian tissue cryopreservation for fertility preservation: clinical and research perspectives vol.2017, pp.1, 2017, https://doi.org/10.1093/hropen/hox001
  11. Diving into the oocyte pool vol.29, pp.3, 2014, https://doi.org/10.1097/gco.0000000000000359
  12. In vitro maturation of human immature oocytes for fertility preservation and research material vol.16, pp.3, 2014, https://doi.org/10.1002/rmb2.12042
  13. CB1 cannabinoid receptor drives oocyte maturation and embryo development via PI3K/Akt and MAPK pathways vol.31, pp.8, 2014, https://doi.org/10.1096/fj.201601382rr
  14. Advances in fertility preservation of female patients with hematological malignancies vol.10, pp.11, 2014, https://doi.org/10.1080/17474086.2017.1371009
  15. Optical coherence microscopy as a novel, non-invasive method for the 4D live imaging of early mammalian embryos vol.7, pp.None, 2014, https://doi.org/10.1038/s41598-017-04220-8
  16. The mutual benefits of research in wild animal species and human-assisted reproduction vol.35, pp.4, 2018, https://doi.org/10.1007/s10815-018-1136-2
  17. The Effects of In Vitro Maturation Technique on The Expression of Genes Involved in Embryonic Genome Activation of Human Embryos vol.20, pp.1, 2014, https://doi.org/10.22074/cellj.2018.4804
  18. The effect of short-term exposure of cumulus-oocyte complexes to in vitro maturation medium on yield of mature oocytes and usable embryos in stimulated cycles vol.35, pp.5, 2014, https://doi.org/10.1007/s10815-018-1155-z
  19. Oocyte in vitro maturation: A sytematic review vol.15, pp.2, 2014, https://doi.org/10.4274/tjod.23911
  20. Improvement of oocyte in vitro maturation from mice with polycystic ovary syndrome by human mesenchymal stromal cell–conditioned media vol.119, pp.12, 2014, https://doi.org/10.1002/jcb.27380
  21. Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome vol.11, pp.None, 2018, https://doi.org/10.1186/s13048-018-0445-5
  22. Female Fertility Preservation through Stem Cell-based Ovarian Tissue Reconstitution In Vitro and Ovarian Regeneration In Vivo vol.13, pp.None, 2019, https://doi.org/10.1177/1179558119848007
  23. Implications and Current Limitations of Oogenesis from Female Germline or Oogonial Stem Cells in Adult Mammalian Ovaries vol.8, pp.2, 2014, https://doi.org/10.3390/cells8020093
  24. From bench to bedside: Current developments and future possibilities of artificial human ovary to restore fertility vol.98, pp.5, 2014, https://doi.org/10.1111/aogs.13552
  25. Preserving fertility in female patients with hematological malignancies: a multidisciplinary oncofertility approach vol.30, pp.11, 2014, https://doi.org/10.1093/annonc/mdz284
  26. Luteinizing Hormone Action in Human Oocyte Maturation and Quality: Signaling Pathways, Regulation, and Clinical Impact vol.27, pp.6, 2020, https://doi.org/10.1007/s43032-019-00137-x
  27. Fertility Preservation and Long-Term Monitoring of Gonadotoxicity in Girls, Adolescents and Young Adults Undergoing Cancer Treatment vol.13, pp.2, 2021, https://doi.org/10.3390/cancers13020202
  28. Prospects of Germline Nuclear Transfer in Women With Diminished Ovarian Reserve vol.12, pp.None, 2014, https://doi.org/10.3389/fendo.2021.635370